Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001240 · ClinicalTrials.gov registry record
Evaluating Patients With Abnormal Levels of Gastric Acid
A clinical trial of Gastrinoma and Achlorhydria, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Completed
- Registry status
- 1
- Study location
NCT00001240: Completed study of Gastrinoma and Achlorhydria, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
NCT00001240 is a study of Gastrinoma and Achlorhydria that has completed, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001240, a study of Gastrinoma and Achlorhydria, has completed, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- COMPLETED
- Registry status
- 1
- Study location
Study Summary
This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasogastric suctioning, where a thin plastic tube is passed from the nose to the stomach. Depending on the patient's present condition further diagnostic testing may be required to achieve a diagnosis.
Conditions Studied
Study Locations (1)
Maryland
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) - Bethesda
Trial Details
| Field | Value |
|---|---|
| Start Date | 1989-01 |
| Est. Completion | 2004-01 |
What the finished NCT00001240 record still lists
NCT00001240 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 3 conditions, with Gastrinoma appearing as the primary indexed condition, and to 0 interventions.
NCT00001240 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT00001240 about?
NCT00001240 is a clinical study titled "Evaluating Patients With Abnormal Levels of Gastric Acid". This study is used by the Digestive Diseases Branch to evaluate patients with suspected abnormalities in the secretion of gastric acid. The level of gastric acid is measured by analyzing the gastric juices of each individual patient. The gastric acid sample is obtained by a procedure known as nasoga...
What is the current status of trial NCT00001240?
This trial is currently completed. The study started on 1989-01. Estimated completion is 2004-01.
What conditions does trial NCT00001240 study?
This clinical trial studies the following conditions: Gastrinoma, Achlorhydria, Zollinger Ellison Syndrome.
Who is sponsoring clinical trial NCT00001240?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00001240 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gastrinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
COMPLETED · Phase 1
-
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia